LoginGet started
Picture of Jazz Pharmaceuticals logo

JAZZ — Jazz Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapContrarian
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Jazz Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line523239-330-224415
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items270605311876352
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-150-85.4175283-53
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Cash from Operating Activities7769007791,2721,092
Capital Expenditures-182-379-45.5-498-43
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items27-628-5,16752-120
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-155-1,008-5,212-446-163
Financing Cash Flow Items-16.7-16.9-35.6-45.4-51
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2945283,971-529-305
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash328420-466290625